Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-19-025855
Filing Date
2019-12-11
Accepted
2019-12-11 15:12:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO SCHEDULE 13G sc13g1219a2alpha_akersbio.htm SC 13G/A 33635
  Complete submission text file 0001213900-19-025855.txt   35278
Mailing Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999
Business Address PRADAFAUT 7 FURSTENTUMS 1490 VADUZ LIECHTENSTEIN C4 99999 0114232376363
ALPHA CAPITAL ANSTALT (Filed by) CIK: 0001140358 (see all company filings)

EIN.: 000000000
Type: SC 13G/A

Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Subject) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88005 | Film No.: 191279724
SIC: 2835 In Vitro & In Vivo Diagnostic Substances